Medication info
Vytorin 10/20

Vytorin 10/20

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
White to pale yellow, bilaterally convex rectangular tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201007275 · Notified 2010.11.30 · Insurance code 643103220

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is taken once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10 mg to 10/40 mg once daily. The usual recommended starting dose is 10/20 mg once daily. Patients who require only a modest reduction in LDL cholesterol may start at 10/10 mg once daily. After starting treatment or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks before adjusting the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg of this medicine once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is required when administering this medicine to older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is used as an adjunct to diet for the treatment of patients with primary hypercholesterolemia and mixed hyperlipidemia to reduce elevated total cholesterol, LDL cholesterol, Apo B, and triglycerides while increasing HDL cholesterol. It can be administered as an adjunct or as monotherapy in patients with homozygous familial hypercholesterolemia. This medication should be used alongside a proper diet, which includes restriction of saturated fats and cholesterol, and is administered when the response to dietary and non-pharmacological measures is inadequate. It is important to identify and treat any secondary causes of dyslipidemia before use. Regular lipid testing should be performed to monitor treatment effectiveness based on the patient's condition. This medication improves the risk of hypercholesterolemia and associated atherosclerotic vascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is taken once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10 mg to 10/40 mg once daily. The usual recommended starting dose is 10/20 mg once daily. Patients who require only a modest reduction in LDL cholesterol may start at 10/10 mg once daily. After starting treatment or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks before adjusting the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg of this medicine once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is required when administering this medicine to older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication poses a risk of severe muscle problems such as myopathy or rhabdomyolysis, so if symptoms of muscle pain or weakness occur, you should consult a doctor immediately. This medication should not be used in patients with certain liver diseases, or in women who are pregnant or breastfeeding. Additionally, it is crucial to inform the physician of any ongoing medications, as it may be dangerous to combine this medication with certain drugs due to potential hypersensitivity reactions. Elderly patients or those with impaired renal function need additional caution when taking this medication, and regular blood tests to check liver function and muscle status are essential. This medication interacts with various other drugs, especially antifungals, antibiotics, calcium channel blockers, and specific antiviral medications, which can increase the risk of muscle damage when co-administered. Women planning for pregnancy or who may be pregnant should consult a doctor before taking this medication, and discontinue use immediately if pregnancy is confirmed. Women who are breastfeeding are also advised to stop nursing while on this medication. The safety and efficacy of this medication in children or adolescents have not been sufficiently established, and it is not recommended for children under 10 years old. There is no specific antidote in case of overdose, so prompt medical attention is required. During the course of this medication, unusual symptoms such as muscle pain, fatigue, or digestive issues may occur, and healthcare providers should be notified if symptoms persist. Moreover, this medication may slightly elevate blood glucose levels, so regular monitoring of blood glucose is necessary in patients at risk of diabetes. It is advisable to avoid certain foods that may interact with this medication, such as grapefruit juice, and to inform the physician of any new medications being taken.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 92 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • liver damage
  • asthenia
  • ocular muscle paralysis
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • oculomotor disorders
  • facial incomplete paralysis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • memory decline
  • forgetfulness
  • amnesia
  • memory impairment
  • confusion
  • interstitial lung disease
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • alopecia
  • various skin changes
  • lichenoid drug rash
  • gynecomastia
  • decreased libido
  • erectile dysfunction
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is also important to store it at room temperature between 1°C and 30°C to maintain its efficacy.

Appearance and packaging

Appearance

White to pale yellow, bilaterally convex rectangular tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.